L-NMMA Dose-response Study in Healthy Subjects

NCT01070940 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: NG-monomethyl-L-arginine (L-NMMA)
DRUG: NG-monomethyl-L-arginine (L-NMMA)
DRUG: NG-monomethyl-L-arginine (L-NMMA)
DRUG: Placebo

Sponsor

Regional Hospital Holstebro